Overview

Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )

Status:
Completed
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
A study in 2-5 year old children to evaluate the safety and tolerability of montelukast and placebo administered once daily at bed time.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast